We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Compounded Avastin for Off-Label Use Behind Eye Infection Outbreak
Compounded Avastin for Off-Label Use Behind Eye Infection Outbreak
August 31, 2011
Compounded and repackaged syringes of Genentech’s cancer drug Avastin, used off-label for wet age-related macular degeneration, are behind an outbreak of debilitating eye infections in the Miami area.